Cassava Sciences IncNASDAQ:SAVA
- LAST PRICE29.2000
- TODAY'S CHANGE (%)2.1950 (8.1281%)
- Bid / Lots29.1600/ 2
- Ask / Lots29.2000/ 2
- Open / Previous Close27.2600 / 27.0050
- Day Range
- 52 Week Range
- Volume1,402,458
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SAVA |
|---|---|---|
| 09:32 ET | 16338 | 27.24 |
| 09:34 ET | 8355 | 27.435 |
| 09:36 ET | 11826 | 27.73 |
| 09:38 ET | 15988 | 27.635 |
| 09:39 ET | 18196 | 27.5482 |
| 09:41 ET | 5218 | 27.53 |
| 09:43 ET | 12638 | 27.83 |
| 09:45 ET | 8816 | 27.78 |
| 09:48 ET | 19583 | 27.7 |
| 09:50 ET | 8633 | 27.539 |
| 09:52 ET | 8686 | 27.59 |
| 09:54 ET | 5689 | 27.575 |
| 09:56 ET | 8958 | 27.504 |
| 09:57 ET | 40246 | 27.315 |
| 09:59 ET | 3753 | 27.18 |
| 10:01 ET | 7500 | 27.5671 |
| 10:03 ET | 28936 | 27.6396 |
| 10:06 ET | 5574 | 27.77 |
| 10:08 ET | 3977 | 27.691 |
| 10:10 ET | 2961 | 27.705 |
| 10:12 ET | 7089 | 27.69 |
| 10:14 ET | 3651 | 27.8 |
| 10:15 ET | 7837 | 27.72 |
| 10:17 ET | 16162 | 27.805 |
| 10:19 ET | 7796 | 27.79 |
| 10:21 ET | 4686 | 27.61 |
| 10:24 ET | 5321 | 27.49 |
| 10:26 ET | 16605 | 27.54 |
| 10:28 ET | 1985 | 27.57 |
| 10:30 ET | 2305 | 27.595 |
| 10:32 ET | 2864 | 27.46 |
| 10:33 ET | 2589 | 27.54 |
| 10:35 ET | 6533 | 27.58 |
| 10:37 ET | 5926 | 27.4158 |
| 10:39 ET | 763 | 27.39 |
| 10:42 ET | 6354 | 27.46 |
| 10:44 ET | 5703 | 27.3 |
| 10:46 ET | 4758 | 27.235 |
| 10:48 ET | 14593 | 27.21 |
| 10:50 ET | 300 | 27.22 |
| 10:51 ET | 6311 | 27.225 |
| 10:53 ET | 3900 | 27.25 |
| 10:55 ET | 5459 | 27.41 |
| 10:57 ET | 5136 | 27.49 |
| 11:00 ET | 15295 | 27.88 |
| 11:02 ET | 33673 | 28.07 |
| 11:04 ET | 13752 | 27.89 |
| 11:06 ET | 3148 | 27.785 |
| 11:08 ET | 7654 | 27.88 |
| 11:09 ET | 7329 | 28.12 |
| 11:11 ET | 14387 | 28.22 |
| 11:13 ET | 22678 | 28.5607 |
| 11:15 ET | 22209 | 28.59 |
| 11:18 ET | 4903 | 28.645 |
| 11:20 ET | 16212 | 28.7917 |
| 11:22 ET | 8722 | 28.6543 |
| 11:24 ET | 6551 | 28.66 |
| 11:26 ET | 6737 | 28.72 |
| 11:27 ET | 16625 | 28.8629 |
| 11:29 ET | 5850 | 28.68 |
| 11:31 ET | 3730 | 28.7283 |
| 11:33 ET | 8725 | 28.83 |
| 11:36 ET | 7471 | 28.86 |
| 11:38 ET | 26414 | 29.0087 |
| 11:40 ET | 21374 | 28.72 |
| 11:42 ET | 9814 | 28.5499 |
| 11:44 ET | 1405 | 28.64 |
| 11:45 ET | 2070 | 28.59 |
| 11:47 ET | 5608 | 28.4601 |
| 11:49 ET | 25126 | 28.61 |
| 11:51 ET | 8525 | 28.51 |
| 11:54 ET | 2289 | 28.54 |
| 11:56 ET | 2590 | 28.5488 |
| 11:58 ET | 600 | 28.557 |
| 12:00 ET | 800 | 28.61 |
| 12:02 ET | 2663 | 28.5025 |
| 12:03 ET | 6125 | 28.7499 |
| 12:05 ET | 4225 | 28.7 |
| 12:07 ET | 7670 | 28.75 |
| 12:09 ET | 6989 | 29.05 |
| 12:12 ET | 12562 | 29.01 |
| 12:14 ET | 10967 | 28.85 |
| 12:16 ET | 5338 | 28.7 |
| 12:18 ET | 3637 | 28.724 |
| 12:20 ET | 2397 | 28.785 |
| 12:21 ET | 2020 | 28.78 |
| 12:23 ET | 1089 | 28.84 |
| 12:25 ET | 1252 | 28.89 |
| 12:27 ET | 6077 | 28.934 |
| 12:30 ET | 10448 | 29.0101 |
| 12:32 ET | 17764 | 29 |
| 12:34 ET | 18612 | 29.09 |
| 12:36 ET | 2952 | 29.07 |
| 12:38 ET | 6672 | 28.9875 |
| 12:39 ET | 1826 | 29 |
| 12:41 ET | 4156 | 28.98 |
| 12:43 ET | 2661 | 28.885 |
| 12:45 ET | 3520 | 28.9275 |
| 12:48 ET | 2701 | 29 |
| 12:50 ET | 2432 | 29 |
| 12:52 ET | 305 | 28.94 |
| 12:54 ET | 2977 | 29.0732 |
| 12:56 ET | 10064 | 29.115 |
| 12:57 ET | 6929 | 29 |
| 12:59 ET | 6857 | 29.01 |
| 01:01 ET | 350 | 29.035 |
| 01:03 ET | 6741 | 28.775 |
| 01:06 ET | 8263 | 28.9299 |
| 01:08 ET | 3443 | 29.02 |
| 01:10 ET | 10115 | 29.0444 |
| 01:12 ET | 6376 | 29.2499 |
| 01:14 ET | 2164 | 29.195 |
| 01:15 ET | 1700 | 29.14 |
| 01:17 ET | 6203 | 29.14 |
| 01:19 ET | 7351 | 29.2 |
| 01:21 ET | 3700 | 29.15 |
| 01:24 ET | 15135 | 29.03 |
| 01:26 ET | 4210 | 29.05 |
| 01:28 ET | 14889 | 28.85 |
| 01:30 ET | 2360 | 29 |
| 01:32 ET | 2070 | 29 |
| 01:33 ET | 2664 | 29.005 |
| 01:35 ET | 8946 | 29.02 |
| 01:37 ET | 5943 | 29.04 |
| 01:39 ET | 13256 | 28.9431 |
| 01:42 ET | 2461 | 29.06 |
| 01:44 ET | 7736 | 29.28 |
| 01:46 ET | 7302 | 29.31 |
| 01:48 ET | 6209 | 29.25 |
| 01:50 ET | 3210 | 29.22 |
| 01:51 ET | 14962 | 29.11 |
| 01:53 ET | 2816 | 29.0907 |
| 01:55 ET | 1523 | 29.2 |
Today
Sep 9, 2024
DJ Cassava Sciences' Executive Chairman Rick Barry Becomes CEO, from 9:06AM ET on Monday Sep 09, 2024 by Dow Jones
9:06AM ET on Monday Sep 09, 2024 by Dow JonesPress Release: Cassava Sciences Names Rick Barry as Chief Executive Officer, from 8:30AM ET on Monday Sep 09, 2024 by Dow Jones
8:30AM ET on Monday Sep 09, 2024 by Dow JonesCassava Sciences Names Rick Barry as Chief Executive Officer, from 8:30AM ET on Monday Sep 09, 2024 by Dow Jones
8:30AM ET on Monday Sep 09, 2024 by Dow Jones
Sep 3, 2024
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference, from 8:31AM ET on Tuesday Sep 03, 2024 by Dow Jones
8:31AM ET on Tuesday Sep 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cassava Sciences Inc | 1.3B | -72.0x | --- |
Longboard Pharmaceuticals Inc | 1.3B | -15.1x | --- |
Day One Biopharmaceuticals Inc | 1.3B | -7.4x | --- |
Tyra Biosciences Inc | 1.2B | -14.2x | --- |
ARS Pharmaceuticals Inc | 1.4B | -29.2x | --- |
Disc Medicine Inc | 1.4B | -12.8x | --- |
Company Information
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease dementia. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain. It is conducting two randomized placebo-controlled Phase III clinical trials of oral simufilam in patients with Alzheimer’s disease dementia. SavaDx, its lead investigational diagnostic product candidate, is a way to detect the presence of Alzheimer’s disease from a small sample of blood. SavaDx is a research-use only, non-safety related exploratory biomarker.
Contact Information
- Headquarters
- 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300AUSTIN, TX, United States 78731
- Phone
- 512-501-2444
- Fax
- 512-614-0414
Executives
- Non-Executive Independent Chairman of the Board
- Claude Nicaise
- Chief Executive Officer
- Richard Barry
- Chief Financial Officer
- Eric Schoen
- Senior Vice President, General Counsel
- R. Christopher Cook
- Chief Medical Officer
- James Kupiec
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 48.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.62 |
EPS | $-0.41 |
Book Value | $3.25 |
P/E Ratio | -72.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
